These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37328077)

  • 21. Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Nelson MJ; Buckley JD; Thomson RL; Clark D; Kwiatek R; Davison K
    J Transl Med; 2019 Mar; 17(1):80. PubMed ID: 30871578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing Idiopathic Chronic Fatigue and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in Males: Response to Two-Day Cardiopulmonary Exercise Testing Protocol.
    van Campen CLMC; Visser FC
    Healthcare (Basel); 2021 Jun; 9(6):. PubMed ID: 34198946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lv Y; Zhang T; Cai J; Huang C; Zhan S; Liu J
    Front Immunol; 2022; 13():952987. PubMed ID: 36189286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stress-Induced Transcriptomic Changes in Females with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Reveal Disrupted Immune Signatures.
    Van Booven DJ; Gamer J; Joseph A; Perez M; Zarnowski O; Pandya M; Collado F; Klimas N; Oltra E; Nathanson L
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-Dependent Transcriptional Changes in Response to Stress in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Project.
    Gamer J; Van Booven DJ; Zarnowski O; Arango S; Elias M; Kurian A; Joseph A; Perez M; Collado F; Klimas N; Oltra E; Nathanson L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
    Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
    Gravelsina S; Vilmane A; Svirskis S; Rasa-Dzelzkaleja S; Nora-Krukle Z; Vecvagare K; Krumina A; Leineman I; Shoenfeld Y; Murovska M
    Front Immunol; 2022; 13():928945. PubMed ID: 36300129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Domingo JC; Cordobilla B; Ferrer R; Giralt M; Alegre-Martín J; Castro-Marrero J
    Antioxid Redox Signal; 2021 Jun; 34(18):1420-1427. PubMed ID: 33353469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Esfandyarpour R; Kashi A; Nemat-Gorgani M; Wilhelmy J; Davis RW
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10250-10257. PubMed ID: 31036648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
    Front Immunol; 2020; 11():582330. PubMed ID: 33329554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and meta-analysis of urinary biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Taccori A; Maksoud R; Eaton-Fitch N; Patel M; Marshall-Gradisnik S
    J Transl Med; 2023 Jul; 21(1):440. PubMed ID: 37408028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
    PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology.
    Nepotchatykh E; Elremaly W; Caraus I; Godbout C; Leveau C; Chalder L; Beaudin C; Kanamaru E; Kosovskaia R; Lauzon S; Maillet Y; Franco A; Lascau-Coman V; Bouhanik S; Gaitan YP; Li D; Moreau A
    Sci Rep; 2020 Nov; 10(1):19620. PubMed ID: 33184353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis.
    Zhang L; Gough J; Christmas D; Mattey DL; Richards SC; Main J; Enlander D; Honeybourne D; Ayres JG; Nutt DJ; Kerr JR
    J Clin Pathol; 2010 Feb; 63(2):156-64. PubMed ID: 19955554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
    Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S
    BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation.
    Almenar-Pérez E; Ovejero T; Sánchez-Fito T; Espejo JA; Nathanson L; Oltra E
    Clin Ther; 2019 Apr; 41(4):675-698. PubMed ID: 30910331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recursive ensemble feature selection provides a robust mRNA expression signature for myalgic encephalomyelitis/chronic fatigue syndrome.
    Metselaar PI; Mendoza-Maldonado L; Li Yim AYF; Abarkan I; Henneman P; Te Velde AA; Schönhuth A; Bosch JA; Kraneveld AD; Lopez-Rincon A
    Sci Rep; 2021 Feb; 11(1):4541. PubMed ID: 33633136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Gender Differences in HRV of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Mobile-Health Technology.
    Capdevila L; Castro-Marrero J; Alegre J; Ramos-Castro J; Escorihuela RM
    Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating microRNA expression signatures accurately discriminate myalgic encephalomyelitis from fibromyalgia and comorbid conditions.
    Nepotchatykh E; Caraus I; Elremaly W; Leveau C; Elbakry M; Godbout C; Rostami-Afshari B; Petre D; Khatami N; Franco A; Moreau A
    Sci Rep; 2023 Feb; 13(1):1896. PubMed ID: 36732593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.